Qualigen Therapeutics Stock Forecast - Mean Deviation

QLGN Stock  USD 4.62  0.04  0.86%   
Qualigen Stock Forecast is based on your current time horizon. Although Qualigen Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Qualigen Therapeutics' systematic risk associated with finding meaningful patterns of Qualigen Therapeutics fundamentals over time.
  
As of the 30th of November 2024, Asset Turnover is likely to grow to 2.69, while Inventory Turnover is likely to drop 2.96. . As of the 30th of November 2024, Common Stock Shares Outstanding is likely to grow to about 5.3 M, while Net Loss is likely to drop (17.6 M).
On November 26, 2024 Qualigen Therapeutics had Mean Deviation of 0.
Check Qualigen Therapeutics VolatilityBacktest Qualigen TherapeuticsTrend Details  

Qualigen Therapeutics Trading Date Momentum

On November 27 2024 Qualigen Therapeutics was traded for  4.66  at the closing time. The top price for the day was 4.71  and the lowest listed price was  4.33 . The trading volume for the day was 33.9 K. The trading history from November 27, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 4.25% . The trading delta at closing time against the current closing price is 6.71% .
Compare Qualigen Therapeutics to competition

Other Forecasting Options for Qualigen Therapeutics

For every potential investor in Qualigen, whether a beginner or expert, Qualigen Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Qualigen Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Qualigen. Basic forecasting techniques help filter out the noise by identifying Qualigen Therapeutics' price trends.

View Qualigen Therapeutics Related Equities

 Risk & Return  Correlation

Qualigen Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Qualigen Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Qualigen Therapeutics' current price.

Qualigen Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Qualigen Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Qualigen Therapeutics shares will generate the highest return on investment. By undertsting and applying Qualigen Therapeutics stock market strength indicators, traders can identify Qualigen Therapeutics entry and exit signals to maximize returns.

Qualigen Therapeutics Risk Indicators

The analysis of Qualigen Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Qualigen Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting qualigen stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Qualigen Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qualigen Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Qualigen Stock

  0.83BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.8GILD Gilead SciencesPairCorr
  0.75ESPR Esperion Therapeutics Buyout TrendPairCorr
  0.71VTRS ViatrisPairCorr
  0.61BFRIW Biofrontera WarrantsPairCorr
The ability to find closely correlated positions to Qualigen Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qualigen Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qualigen Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qualigen Therapeutics to buy it.
The correlation of Qualigen Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qualigen Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qualigen Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qualigen Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Qualigen Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Qualigen Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qualigen Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qualigen Therapeutics Stock:
Check out Historical Fundamental Analysis of Qualigen Therapeutics to cross-verify your projections.
To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qualigen Therapeutics. If investors know Qualigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qualigen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
3.6 K
Revenue Per Share
1.034
Quarterly Revenue Growth
0.137
Return On Assets
(0.75)
Return On Equity
(8.42)
The market value of Qualigen Therapeutics is measured differently than its book value, which is the value of Qualigen that is recorded on the company's balance sheet. Investors also form their own opinion of Qualigen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Qualigen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qualigen Therapeutics' market value can be influenced by many factors that don't directly affect Qualigen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qualigen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Qualigen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qualigen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.